Weekly Dupilumab Beneficial in Eosinophilic Esophagitis

THURSDAY, Dec. 22, 2022 -- Subcutaneous dupilumab administered weekly is associated with improved histologic outcomes and alleviation of symptoms among patients with eosinophilic esophagitis, according to a study published in the Dec. 22 issue of...